Bedell Frazier Investment Counselling’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.89M | Sell |
7,415
-406
| -5% | -$213K | 0.98% | 33 |
|
|
2025
Q1 | $4.96M | Buy |
7,821
+2,916
| +59% | +$1.85M | 1.26% | 26 |
|
|
2024
Q4 | $3.49M | Buy |
4,905
+92
| +2% | +$65.5K | 0.87% | 36 |
|
|
2024
Q3 | $5.06M | Sell |
4,813
-41
| -0.8% | -$43.1K | 1.21% | 30 |
|
|
2024
Q2 | $5.1M | Sell |
4,854
-1,960
| -29% | -$2.06M | 1.23% | 32 |
|
|
2024
Q1 | $6.56M | Sell |
6,814
-60
| -0.9% | -$57.7K | 1.64% | 23 |
|
|
2023
Q4 | $6.04M | Sell |
6,874
-63
| -0.9% | -$55.3K | 1.66% | 23 |
|
|
2023
Q3 | $5.71M | Sell |
6,937
-3,176
| -31% | -$2.61M | 1.71% | 23 |
|
|
2023
Q2 | $7.27M | Sell |
10,113
-447
| -4% | -$321K | 2.13% | 17 |
|
|
2023
Q1 | $8.68M | Sell |
10,560
-205
| -2% | -$168K | 2.54% | 13 |
|
|
2022
Q4 | $7.77M | Sell |
10,765
-304
| -3% | -$219K | 2.03% | 16 |
|
|
2022
Q3 | $7.63M | Sell |
11,069
-60
| -0.5% | -$41.3K | 2.14% | 16 |
|
|
2022
Q2 | $6.58M | Sell |
11,129
-80
| -0.7% | -$47.3K | 2.02% | 20 |
|
|
2022
Q1 | $7.83M | Sell |
11,209
-124
| -1% | -$86.6K | 1.98% | 17 |
|
|
2021
Q4 | $7.16M | Buy |
11,333
+68
| +0.6% | +$42.9K | 1.74% | 20 |
|
|
2021
Q3 | $6.82M | Sell |
11,265
-2,923
| -21% | -$1.77M | 1.87% | 20 |
|
|
2021
Q2 | $7.93M | Buy |
14,188
+280
| +2% | +$156K | 2.01% | 16 |
|
|
2021
Q1 | $6.58M | Buy |
13,908
+5,714
| +70% | +$2.7M | 1.86% | 23 |
|
|
2020
Q4 | $3.96M | Buy |
8,194
+3,993
| +95% | +$1.93M | 1.21% | 33 |
|
|
2020
Q3 | $2.35M | Sell |
4,201
-88
| -2% | -$49.3K | 0.84% | 37 |
|
|
2020
Q2 | $2.68M | Sell |
4,289
-25
| -0.6% | -$15.6K | 1.08% | 30 |
|
|
2020
Q1 | $2.11M | Buy |
+4,314
| New | +$2.11M | 0.99% | 31 |
|